Literature DB >> 20718815

Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines.

Allan R Brasier1, Sundar Victor, Hyunsu Ju, William W Busse, Douglas Curran-Everett, Eugene Bleecker, Mario Castro, Kian Fan Chung, Benjamin Gaston, Elliot Israel, Sally E Wenzel, Serpil C Erzurum, Nizar N Jarjour, William J Calhoun.   

Abstract

An important problem in realizing personalized medicine is the development of methods for identifying disease subtypes using quantitative proteomics. Recently we found that bronchoalveolar lavage (BAL) cytokine patterns contain information about dynamic lung responsiveness. In this study, we examined physiological data from 1,048 subjects enrolled in the US Severe Asthma Research Program (SARP) to identify four largely separable, quantitative intermediate phenotypes. Upper extremes in the study population were identified for eosinophil- or neutrophil-predominant inflammation, bronchodilation in response to albuterol treatment, or methacholine sensitivity. We evaluated four different statistical ("machine") learning methods to predict each intermediate phenotype using BAL A-cytokine measurements on a 76 subject subset. Comparison of these models using area under the ROC curve and overall classification accuracy indicated that logistic regression and multivariate adaptive regression splines produced the most accurate methods to predict intermediate asthma phenotypes. These robust classification methods will aid future translational studies in asthma targeted at specific intermediate phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718815      PMCID: PMC3021493          DOI: 10.1111/j.1752-8062.2010.00204.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  46 in total

1.  Relationship of small airway chymase-positive mast cells and lung function in severe asthma.

Authors:  Silvana Balzar; Hong Wei Chu; Matthew Strand; Sally Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2004-11-24       Impact factor: 21.405

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 3.  Viruses in asthma exacerbations.

Authors:  Wan C Tan
Journal:  Curr Opin Pulm Med       Date:  2005-01       Impact factor: 3.155

4.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Authors:  L Jayaram; M M Pizzichini; R J Cook; L-P Boulet; C Lemière; E Pizzichini; A Cartier; P Hussack; C H Goldsmith; M Laviolette; K Parameswaran; F E Hargreave
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

5.  Eosinophilic inflammation in asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; G Barnéon; N Ghavanian; I Enander; P Venge; S Ahlstedt; J Simony-Lafontaine; P Godard
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

6.  The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.

Authors:  Ilaria Puxeddu; Reem Bader; Adrian Martin Piliponsky; Reuven Reich; Francesca Levi-Schaffer; Neville Berkman
Journal:  J Allergy Clin Immunol       Date:  2005-12-02       Impact factor: 10.793

7.  Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils.

Authors:  M A Cassatella; S Gasperini; F Calzetti; A Bertagnin; A D Luster; P P McDonald
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

8.  Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle.

Authors:  H Hakonarson; N Maskeri; C Carter; S Chuang; M M Grunstein
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

9.  Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.

Authors:  H A Kerstjens; S E Overbeek; J P Schouten; P L Brand; D S Postma
Journal:  Eur Respir J       Date:  1993-06       Impact factor: 16.671

10.  The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking.

Authors:  Daniel L Venarske; William W Busse; Marie R Griffin; Tebeb Gebretsadik; Ayumi K Shintani; Patricia A Minton; R Stokes Peebles; Robert Hamilton; Elizabeth Weisshaar; Rose Vrtis; Stanley B Higgins; Tina V Hartert
Journal:  J Infect Dis       Date:  2006-04-27       Impact factor: 5.226

View more
  29 in total

1.  Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression.

Authors:  Regina R Pillai; Rohit Divekar; Allan Brasier; Suresh Bhavnani; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

2.  Molecular classification of outcomes from dengue virus -3 infections.

Authors:  Allan R Brasier; Yingxin Zhao; John E Wiktorowicz; Heidi M Spratt; Eduardo J M Nascimento; Marli T Cordeiro; Kizhake V Soman; Hyunsu Ju; Adrian Recinos; Susan Stafford; Zheng Wu; Ernesto T A Marques; Nikos Vasilakis
Journal:  J Clin Virol       Date:  2015-01-17       Impact factor: 3.168

3.  Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.

Authors:  Allan R Brasier; Josefina Garcia; John E Wiktorowicz; Heidi M Spratt; Guillermo Comach; Hyunsu Ju; Adrian Recinos; Kizhake Soman; Brett M Forshey; Eric S Halsey; Patrick J Blair; Claudio Rocha; Isabel Bazan; Sundar S Victor; Zheng Wu; Susan Stafford; Douglas Watts; Amy C Morrison; Thomas W Scott; Tadeusz J Kochel
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

4.  How cytokines co-occur across asthma patients: from bipartite network analysis to a molecular-based classification.

Authors:  Suresh K Bhavnani; Sundar Victor; William J Calhoun; William W Busse; Eugene Bleecker; Mario Castro; Hyunsu Ju; Regina Pillai; Numan Oezguen; Gowtham Bellala; Allan R Brasier
Journal:  J Biomed Inform       Date:  2011-10-01       Impact factor: 6.317

5.  Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge.

Authors:  M W Johansson; K A Gunderson; E A B Kelly; L C Denlinger; N N Jarjour; D F Mosher
Journal:  Clin Exp Allergy       Date:  2013-03       Impact factor: 5.018

6.  Elevated levels of NO are localized to distal airways in asthma.

Authors:  John T Anderson; Meiqin Zeng; Qian Li; Ryan Stapley; Doyle Ray Moore; Balachandra Chenna; Naomi Fineberg; Jaroslaw Zmijewski; Isam-Eldin Eltoum; Gene P Siegal; Amit Gaggar; Stephen Barnes; Sadanandan E Velu; Victor J Thannickal; Edward Abraham; Rakesh P Patel; Jack R Lancaster; David D Chaplin; Mark T Dransfield; Jessy S Deshane
Journal:  Free Radic Biol Med       Date:  2011-03-16       Impact factor: 7.376

Review 7.  Identification of innate immune response endotypes in asthma: implications for personalized medicine.

Authors:  Allan R Brasier
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 8.  A structured approach to predictive modeling of a two-class problem using multidimensional data sets.

Authors:  Heidi Spratt; Hyunsu Ju; Allan R Brasier
Journal:  Methods       Date:  2013-01-12       Impact factor: 3.608

9.  Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease.

Authors:  Rebecca A Martin; Jennifer L Ather; Lennart K A Lundblad; Benjamin T Suratt; Jonathan E Boyson; Ralph C Budd; John F Alcorn; Richard A Flavell; Stephanie C Eisenbarth; Matthew E Poynter
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

Review 10.  Severe Asthma in Children: Lessons Learned and Future Directions.

Authors:  Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.